Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.19.3.a.u2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 12,123 $ 5,342
Premium and trade receivables 6,247 5,150
Short-term investments 863 722
Other current assets 1,090 784
Total current assets 20,323 11,998
Long-term investments 7,717 6,861
Restricted deposits 658 555
Property, software and equipment, net 2,121 1,706
Goodwill 6,863 7,015
Intangible assets, net 2,063 2,239
Other long-term assets 1,249 527
Total assets 40,994 30,901
Current liabilities:    
Medical claims liability 7,473 6,831
Accounts payable and accrued expenses 4,164 4,051
Return of premium payable 824 666
Unearned revenue 383 385
Current portion of long-term debt 88 38
Total current liabilities 12,932 11,971
Long-term debt 13,638 6,648
Other long-term liabilities 1,732 1,259
Total liabilities 28,302 19,878
Commitments and contingencies
Redeemable noncontrolling interests 33 10
Stockholders' equity:    
Preferred stock, $.001 par value; authorized 10,000 shares; no shares issued or outstanding at December 31, 2019 and December 31, 2018 0 0
Common stock, $.001 par value; authorized 800,000 shares; 421,508 issued and 415,048 outstanding at December 31, 2019, and 417,695 issued and 412,478 outstanding at December 31, 2018 0 0
Additional paid-in capital 7,647 7,449
Accumulated other comprehensive earnings (loss) 134 (56)
Retained earnings 4,984 3,663
Treasury stock, at cost (6,460 and 5,217 shares, respectively) (214) (139)
Total Centene stockholders' equity 12,551 10,917
Noncontrolling interest 108 96
Total stockholders' equity 12,659 11,013
Total liabilities, redeemable noncontrolling interests and stockholders' equity $ 40,994 $ 30,901